findmyKOL
Clinical trialNCT01827722UnknownPhase 4Interventional

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion

SponsorValley Retina InstituteEnrollment45Central Retinal Vein OcclusionMacular Edema
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Retina Vitreous Associates Medical Group

    Beverly Hills, California, United States

    David S Boyer, MD
    Recruiting
  • Retina Associates

    Lakeland, Florida, United States

    David Boyer, MD
    Recruiting
  • Center for Retina and Macular Disease

    Winter Haven, Florida, United States

    Michael Tolentino, MD
    Recruiting
  • Valley Retina Institute, Pa

    Harlingen, Texas, United States

    Victor H. Gonzalez, MD
    Recruiting
  • Valley Retina Institute, Pa

    McAllen, Texas, United States

    Victor H Gonzalez, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2013
Primary completion
31 May 2016
Completion
31 Dec 2016
Last update posted
14 Dec 2015
Registered enrollment
45
Registry id
NCT01827722

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.